Lerasan, Elsa L.
HRN: 22-58-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
CEFTAZIDIME 1GM (VIAL)
02/10/2023
02/17/2023
IV
1 Gram
Q8
Cap-mr; Copd In Ae
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes